FDA Inspection 1270097 — Mindaugas Jievaltas, MD, PhD
The FDA completed an inspection of Mindaugas Jievaltas, MD, PhD on Apr 17, 2025 in Zaliakalnis. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 17, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Zaliakalnis (Lithuania)
Additional details
Clinical Investigator (CI)